Globus Medical (GMED) has issued an update.
On June 5, 2024, Globus Medical, Inc. stockholders, during their Annual Meeting, greenlit an amendment to the 2021 Equity Incentive Plan, following recommendations from the Board of Directors and its Compensation Committee. Additionally, they elected four directors to the Board for three-year terms, ratified the appointment of Deloitte & Touche LLP as the independent auditor for the upcoming fiscal year, and approved executive compensation in a non-binding vote. The detailed results of the votes on these proposals showcased shareholder engagement and approval for the company’s strategic decisions.
For an in-depth examination of GMED stock, go to TipRanks’ Stock Analysis page.
